Glaucotensil
Brand names,
Glaucotensil
Analogs
Glaucotensil
Brand Names Mixture
Glaucotensil
Chemical_Formula
C9H10N2O3S2
Glaucotensil
RX_link
No information avaliable
Glaucotensil
fda sheet
Glaucotensil
msds (material safety sheet)
Glaucotensil
Synthesis Reference
No information avaliable
Glaucotensil
Molecular Weight
258.319 g/mol
Glaucotensil
Melting Point
189 oC
Glaucotensil
H2O Solubility
40 mg/L
Glaucotensil
State
Solid
Glaucotensil
LogP
1.218
Glaucotensil
Dosage Forms
Tablet (125, 250 mg); Capsule (500mg); Injection (500mg)
Glaucotensil
Indication
For use in the treatment of duodenal ulcers, as a diuretic, and in the treatment of glaucoma, and may also be useful in the treatment of seizures associated with epilepsy.
Glaucotensil
Pharmacology
Ethoxzolamide, a sulfonamide, inhibits carbonic anhydrase activity in proximal renal tubules to decrease reabsorption of water, sodium, potassium, bicarbonate. It also decreases carbonic anhydrase in the CNS, increasing the seizure threshold. This reduction in carbonic anhydrase also reduces the intraocular pressure in the eye by decreasing aqueous humor.
Glaucotensil
Absorption
Rapidly absorbed with 65% bioavailability
Glaucotensil
side effects and Toxicity
No information avaliable
Glaucotensil
Patient Information
Glaucotensil
Organisms Affected
Humans and other mammals